000 | 01762 a2200505 4500 | ||
---|---|---|---|
005 | 20250513152806.0 | ||
264 | 0 | _c19981022 | |
008 | 199810s 0 0 eng d | ||
022 | _a0022-1767 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPeters, M | |
245 | 0 | 0 |
_aIn vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cOct 1998 |
||
300 |
_a3575-81 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcute-Phase Reaction _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 | _aCytokine Receptor gp130 |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 |
_aHaptoglobins _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections, Intraperitoneal |
650 | 0 | 4 |
_aInterleukin-6 _xadministration & dosage |
650 | 0 | 4 |
_aIodine Radioisotopes _xmetabolism |
650 | 0 | 4 |
_aLiver _xdrug effects |
650 | 0 | 4 |
_aMembrane Glycoproteins _xmetabolism |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aProtein Binding |
650 | 0 | 4 |
_aRNA, Messenger _xbiosynthesis |
650 | 0 | 4 |
_aReceptors, Interleukin _xadministration & dosage |
650 | 0 | 4 | _aReceptors, Interleukin-6 |
650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aBlinn, G | |
700 | 1 | _aSolem, F | |
700 | 1 | _aFischer, M | |
700 | 1 | _aMeyer zum Büschenfelde, K H | |
700 | 1 | _aRose-John, S | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 161 _gno. 7 _gp. 3575-81 |
|
999 |
_c9724718 _d9724718 |